Lam Research Corp
NASDAQ:LRCX
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
70.05
112.3882
|
| Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
3M Co
NYSE:MMM
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Walmart Inc
NYSE:WMT
|
US |
|
|
Verizon Communications Inc
NYSE:VZ
|
US |
This alert will be permanently deleted.
Lam Research Corp
Wall Street
Price Targets
LRCX Price Targets Summary
Lam Research Corp
According to Wall Street analysts, the average 1-year price target for
LRCX
is 96.18 USD
with a low forecast of 75.75 USD and a high forecast of 119.7 USD.
LRCX Last Price Targets
Lam Research Corp
The latest public price target was made on Oct 24, 2024 by
Melissa Weathers
from
Deutsche Bank
,
who expects
LRCX
stock to
rise by 4%
over the next 12 months.
You can read more about this price target by viewing
the article on StreetInsider.
| Analyst | Price Target | Date | Article |
|---|---|---|---|
Melissa Weathers
Deutsche Bank
|
75
USD
Upside 4% |
1 month ago
Oct 24, 2024
|
Lam Research (LRCX) PT Lowered to $75 at Deutsche Bank
StreetInsider
|
Brian Chin
Stifel Nicolaus
|
105
USD
Upside 46% |
2 months ago
Oct 22, 2024
|
Stifel Reiterates Buy Rating on Lam Research (LRCX)
StreetInsider
|
|
Craig Ellis
B.Riley Financial
|
105
USD
Upside 46% |
2 months ago
Oct 22, 2024
|
Lam Research (LRCX) PT Lowered to $105 at B.Riley
StreetInsider
|
Srini Pajjuri
Raymond James
|
100
USD
Upside 39% |
2 months ago
Oct 15, 2024
|
Lam Research (LRCX) PT Lowered to $100 at Raymond James
StreetInsider
|
Joseph Moore
Morgan Stanley
|
77
USD
Upside 7% |
2 months ago
Oct 3, 2024
|
Lam Research (LRCX) PT Lowered to $77 at Morgan Stanley Post 10:1 Split
StreetInsider
|
Vijay Rakesh
Mizuho Securities
|
950
USD
Upside 1 223% |
3 months ago
Sep 20, 2024
|
Lam Research (LRCX) PT Lowered to $950 at Mizuho
StreetInsider
|
|
Vijay Rakesh
Mizuho Securities
|
1 050
USD
Upside 1 363% |
3 months ago
Sep 12, 2024
|
Mizuho Reiterates Outperform Rating on Lam Research (LRCX)
StreetInsider
|
Timothy Arcuri
UBS
|
1 150
USD
Upside 1 502% |
3 months ago
Sep 12, 2024
|
Lam Research price target lowered to $1,150 from $1,250 at UBS
TheFly
|
Tom O'Malley
Barclays
|
900
USD
Upside 1 154% |
6 months ago
Jun 5, 2024
|
Lam Research price target raised to $900 from $865 at Barclays
TheFly
|
Joseph Quatrochi
Wells Fargo
|
980
USD
Upside 1 265% |
7 months ago
May 22, 2024
|
Wells Fargo Reiterates Equal Weight Rating on Lam Research (LRCX)
StreetInsider
|
|
Craig Ellis
B.Riley Financial
|
1 130
USD
Upside 1 474% |
7 months ago
Apr 25, 2024
|
Lam Research (LRCX) PT Raised to $1,130 at B.Riley
StreetInsider
|
|
Tom O'Malley
Barclays
|
865
USD
Upside 1 105% |
7 months ago
Apr 25, 2024
|
Lam Research price target raised to $865 from $825 at Barclays
TheFly
|
Charles Shi
Needham
|
950
USD
Upside 1 223% |
7 months ago
Apr 25, 2024
|
Lam Research Expects 2024 To Be A 'Transition Year,' 4 Analysts Provide Key Q3 Takeaways
Benzinga
|
Mehdi Hosseini
Susquehanna
|
850
USD
Upside 1 084% |
7 months ago
Apr 25, 2024
|
Lam Research (LRCX) PT Lowered to $850 at Susquehanna
StreetInsider
|
|
Vijay Rakesh
Mizuho Securities
|
960
USD
Upside 1 237% |
7 months ago
Apr 25, 2024
|
Lam Research (LRCX) PT Raised to $960 at Mizuho
StreetInsider
|
|
Craig Ellis
B.Riley Financial
|
1 100
USD
Upside 1 432% |
8 months ago
Apr 19, 2024
|
B.Riley Upgrades Lam Research (LRCX) to Buy
StreetInsider
|
|
Quinn Bolton
Needham
|
1 030
USD
Upside 1 335% |
8 months ago
Apr 18, 2024
|
Lam Research (LRCX) PT Raised to $1,030 at Needham
StreetInsider
|
|
Brian Chin
Stifel Nicolaus
|
1 050
USD
Upside 1 363% |
8 months ago
Apr 16, 2024
|
Lam Research (LRCX) PT Raised to $1,050 at Stifel
StreetInsider
|
|
Melissa Weathers
Deutsche Bank
|
1 000
USD
Upside 1 293% |
8 months ago
Apr 11, 2024
|
Deutsche Bank Starts Lam Research (LRCX) at Hold
StreetInsider
|
|
Timothy Arcuri
UBS
|
1 130
USD
Upside 1 474% |
8 months ago
Apr 8, 2024
|
UBS says Lam Research (LRCX) is only SPE stock they have a Buy rating on
StreetInsider
|
|
Charles Shi
Needham
|
800
USD
Upside 1 014% |
1 year ago
Oct 19, 2023
|
Lam Research Faces Analyst Scrutiny Over Near-Term Margin and China Demand Uncertainties
Benzinga
|
|
Mehdi Hosseini
Susquehanna
|
615
USD
Upside 757% |
1 year ago
Oct 19, 2023
|
Lam Research Faces Analyst Scrutiny Over Near-Term Margin and China Demand Uncertainties
Benzinga
|
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is LRCX's stock price target?
Price Target
96.18
USD
According to Wall Street analysts, the average 1-year price target for
LRCX
is 96.18 USD
with a low forecast of 75.75 USD and a high forecast of 119.7 USD.
What is Lam Research Corp's Revenue forecast?
Projected CAGR
14%
For the last 8 years the
compound annual growth rate for
Lam Research Corp's revenue is
12%.
The projected
CAGR
for the next 3 years is
14%.
What is Lam Research Corp's Operating Income forecast?
Projected CAGR
17%
For the last 8 years the
compound annual growth rate for
Lam Research Corp's operating income is
19%.
The projected
CAGR
for the next 3 years is
17%.
What is Lam Research Corp's Net Income forecast?
Projected CAGR
18%
For the last 8 years the
compound annual growth rate for
Lam Research Corp's net income is
20%.
The projected
CAGR
for the next 3 years is
18%.
You don't have any saved screeners yet
